Pacira BioSciences, Inc. PCRX Treasury Stock
Treasury Stock at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s treasury stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s treasury stock?
- Pacira BioSciences, Inc. (PCRX) reported treasury stock of $227.01M in Q1 2026.
- How has Pacira BioSciences, Inc.'s treasury stock changed year-over-year?
- Pacira BioSciences, Inc.'s treasury stock increased by 803.7% year-over-year, from $25.12M to $227.01M.
- What does treasury stock mean?
- Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.